<DOC>
	<DOCNO>NCT01802697</DOCNO>
	<brief_summary>This first man study assess safety tolerability IgG cleave enzyme Immunoglobuli G degrade enzyme streptococcus pyogenes ( IdeS ) .</brief_summary>
	<brief_title>Safety Study IdeS Healthy Volounteers</brief_title>
	<detailed_description>A phase I study ( 11-HMedIdeS-01 , EudraCT . 2012-000 969-21 ) first man single ascend dose study 29 healthy subject investigate IdeS safe well tolerated dos 0.24 mg/kg body weight ( BW ) .</detailed_description>
	<criteria>Ability understand sign inform consent BMI 1930 Clinically significant disease Positive HIV , hepatistis B C Drug abuse Smoking Use medication except paracetamol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>volunteer</keyword>
</DOC>